Advertisement

Metabolomics

, 15:153 | Cite as

The anti-inflammatory effects of formononetin and ononin on lipopolysaccharide-induced zebrafish models based on lipidomics and targeted transcriptomics

  • Liyu Luo
  • Junyi Zhou
  • Haiyu Zhao
  • Miaoxuan FanEmail author
  • Wenyuan GaoEmail author
Original Article
  • 25 Downloads

Abstract

Introduction

Formononetin (MBHS) and its glycosylated derivative ononin (MBHG), as the major isoflavones, have exhibited the anti-inflammatory impacts on the lipopolysaccharide (LPS)-induced inflammation. Although various researches have focused on interpreting the pharmaceutical activities of MBHG and MBHS, the molecular mechanisms in zebrafish models are still unclear.

Objective

The purpose of the present work is to investigate the molecular mechanisms of the anti-inflammatory effects of MGHG and MBHS based on lipidomics and targeted transcriptomics.

Methods

UHPLC-MS was applied for the lipid analyses and RT-PCR was adopted for the mRNA analyses, and the results of different groups were compared for exploring the significantly changed lipids and mRNAs.

Results

The results of lipidomics revealed that phosphatidylcholines (PCs) were drastically down-regulated in the MBHG or MBHS treated LPS-induced inflammatory zebrafish models. Besides, MBHS can also decrease the levels of triacylglycerols (TAGs). For the targeted transcriptomics analyses, 4 cytokines (TNF-α, IL-1β, IL-6 and IFN-γ) and 3 mRNA (JNK1, ERK1 and p38a) involved in the MAPK pathway were down-regulated and IL-10 was up-regulated under the treatment of MBHG or MBHS.

Conclusion

Combining the results of lipidomics and targeted transcriptomics, we indicated that MBHG and MBHS exerted potent anti-inflammatory effects on the LPS-induced zebrafish models through the MyD88 or TRIF MAPK/ERK and MAPK/JNK pathways and the glycerophospholipid, glycosylphosphatidylinositol (GPI)-anchor biosynthesis and glycerolipid metabolisms. Our results provided new insights into the anti-inflammatory mechanisms of MBHG or MBHS and supplied an effective method to interpret the pharmacological mechanisms of drugs.

Keywords

Formononetin Ononin Inflammation Lipidomics Targeted transcriptomics MAPK 

Notes

Acknowledgements

This work was supported by Major International S&T Cooperation Project from Ministry of Science and Technology of the People’s Republic of China (2016YFE0129000) and Fundamental Research Funds for the Central Public Welfare Research Institutes (No. ZZ10-007).

Author contributions

LL, HZ, MF and WG designed the study. LL and JZ were responsible for doing the experiments and analyzing the data. LL wrote the article. HZ, MF and WG revised the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The experiments based on zebrafish samples were performed in accordance with the guidelines from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) approved by Hunter Biotechnology Co. Ltd. (Hangzhou, China) with the Approval Number as SYXK 2012-0171.

Supplementary material

11306_2019_1614_MOESM1_ESM.docx (1.8 mb)
Supplementary material 1 (DOCX 1864 kb)

References

  1. Annemarie, H. M., & Herman, P. S. (2011). Host-pathogen interactions made transparent with the zebrafish model. Current Drug Targets, 12, 1000–1017.CrossRefGoogle Scholar
  2. Bäck, M., & Hansson, G. K. (2015). Anti-inflammatory therapies for atherosclerosis. Nature Reviews Cardiology, 12, 199.CrossRefGoogle Scholar
  3. Beutler, B., & Rietschel, E. T. (2003). Innate immune sensing and its roots: the story of endotoxin. Nature Reviews Immunology, 3, 169.CrossRefGoogle Scholar
  4. Bretaud, S., Allen, C., Ingham, P. W., & Bandmann, O. (2007). p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson’s disease. Journal of Neurochemistry, 100, 1626–1635.PubMedGoogle Scholar
  5. Chu, A. J. (1992). Bacterial lipopolysaccharide stimulates phospholipid synthesis and phosphatidylcholine breakdown in cultured human leukemia monocytic THP-1 cells. International Journal of Biochemistry, 24, 317–323.CrossRefGoogle Scholar
  6. Clifton-Bligh, P. B., Nery, M. L., Clifton-Bligh, R. J., Visvalingam, S., Fulcher, G. R., Byth, K., et al. (2015). Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition, 69, 134–142.CrossRefGoogle Scholar
  7. Conway, E. M., Pikor, L. A., Kung, S. H., Hamilton, M. J., Lam, S., Lam, W. L., et al. (2016). Macrophages, Inflammation, and Lung Cancer. American Journal of Respiratory and Critical Care Medicine, 193, 116–130.CrossRefGoogle Scholar
  8. Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007). Mass spectrometry-based metabolomics. Mass Spectrometry Reviews, 26, 51–78.CrossRefGoogle Scholar
  9. Donath, M. Y., & Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11, 98–107.CrossRefGoogle Scholar
  10. Dong, L., Yin, L., Zhang, Y., Fu, X., & Lu, J. (2017). Anti-inflammatory effects of ononin on lipopolysaccharide-stimulated RAW 264.7 cells. Molecular Immunology, 83, 46–51.CrossRefGoogle Scholar
  11. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice, 105, 141–150.CrossRefGoogle Scholar
  12. Grove, R. I., Allegretto, N. J., Kiener, P. A., & Warr, G. A. (1990). Lipopolysaccharide (LPS) alters phosphatidylcholine metabolism in elicited peritoneal macrophages. Journal of Leukocyte Biology, 48, 38–42.CrossRefGoogle Scholar
  13. Guan, M., Dai, D., Li, L., Wei, J., Yang, H., Li, S., et al. (2017). Comprehensive qualification and quantification of triacylglycerols with specific fatty acid chain composition in horse adipose tissue, human plasma and liver tissue. Talanta, 172, 206–214.CrossRefGoogle Scholar
  14. Hoo, R. L. C., Wong, J. Y. L., Qiao, C. F., Xu, A., Xu, H. X., & Lam, K. S. L. (2010). The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity. Nutrition & Metabolism, 7, 67.CrossRefGoogle Scholar
  15. Lee, J. W., Mok, H. J., Lee, D. Y., Park, S. C., Kim, G. S., Lee, S. E., et al. (2017). UPLC-QqQ/MS-based lipidomics approach to characterize lipid alterations in inflammatory macrophages. Journal of Proteome Research, 16, 1460–1469.CrossRefGoogle Scholar
  16. Li, Z., Zeng, G., Zheng, X., Wang, W., Ling, Y., Tang, H., et al. (2018). Neuroprotective effect of formononetin against TBI in rats via suppressing inflammatory reaction in cortical neurons. Biomedicine & Pharmacotherapy, 106, 349–354.CrossRefGoogle Scholar
  17. Ma, Z., Ji, W., Fu, Q., & Ma, S. (2013). Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression. Inflammation, 36, 1560–1566.CrossRefGoogle Scholar
  18. Mu, H., Bai, Y. H., Wang, S. T., Zhu, Z. M., & Zhang, Y. W. (2009). Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover). Phytomedicine, 16, 314–319.CrossRefGoogle Scholar
  19. Novoa, B., Bowman, T. V., Zon, L., & Figueras, A. (2009). LPS response and tolerance in the zebrafish (Danio rerio). Fish & Shellfish Immunology, 26, 326–331.CrossRefGoogle Scholar
  20. Novoa, B., & Figueras, A. (2012). Zebrafish: model for the study of inflammation and the innate immune response to infectious diseases. Advances in Experimental Medicine and Biology, 946, 253–275.CrossRefGoogle Scholar
  21. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., et al. (2007). Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature, 447, 1116.CrossRefGoogle Scholar
  22. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011). Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology, 29, 71–109.CrossRefGoogle Scholar
  23. Qiu, L., Ye, H., Chen, L., Hong, Y., Zhong, F., & Zhang, T. (2012). Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARalpha. Phytotherapy Research, 26, 860–864.CrossRefGoogle Scholar
  24. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., et al. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. The FASEB Journal, 8, 217–225.CrossRefGoogle Scholar
  25. Takeda, K., & Akira, S. (2005). Toll-like receptors in innate immunity. International Immunology, 17, 1–14.CrossRefGoogle Scholar
  26. Xu, N., & An, J. (2017). Formononetin ameliorates mast cell-mediated allergic inflammation via inhibition of histamine release and production of pro-inflammatory cytokines. Experimental and Therapeutic Medicine, 14, 6201–6206.PubMedPubMedCentralGoogle Scholar
  27. Zhang, G., He, P., Tan, H., Budhu, A., Gaedcke, J., Ghadimi, B. M., et al. (2013). Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clinical Cancer Research, 19, 4983–4993.CrossRefGoogle Scholar
  28. Zhang, J., Liu, L., Wang, J., Ren, B., Zhang, L., & Li, W. (2018). Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells. Journal of Ethnopharmacology, 221, 91–99.CrossRefGoogle Scholar
  29. Zhang, J.-Y., Jin, H., Wang, G.-F., Yu, P.-J., Wu, S.-Y., Zhu, Z.-G., et al. (2011). Methyl-1-hydroxy-2-naphthoate, a novel naphthol derivative, inhibits lipopolysaccharide-induced inflammatory response in macrophages via suppression of NF-κB, JNK and p38 MAPK pathways. Inflammation Research, 60, 851–859.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of Pharmaceutical Science and TechnologyTianjin UniversityTianjinChina
  2. 2.Institute of Chinese Materia MedicaChina Academy of Chinese Medical SciencesBeijingChina
  3. 3.Beijing Key Laboratory of Analysis and Evaluation on Chinese MedicineBeijing Institute of Drug ControlBeijingChina

Personalised recommendations